Executive Pharmacovigilance
OR
Last updated on 11 May 2026
Overview
An Executive in Pharmacovigilance is responsible for ensuring the safety of pharmaceutical products throughout their lifecycle. This role involves monitoring, identifying, and analyzing adverse effects associated with drugs. They collaborate with cross-functional teams to ensure regulatory compliance and patient safety. The individual in this role plays a key part in risk management strategies and in safeguarding public health. They are also responsible for reporting and analyzing adverse drug reactions (ADRs) to regulatory bodies.
Job Description
- Monitor and report adverse drug reactions (ADRs) from clinical trials and post-marketing surveillance.
- Ensure the timely reporting of safety data to regulatory authorities and stakeholders.
- Conduct thorough analysis and risk assessments of drug safety data to identify trends and safety signals.
- Maintain accurate documentation of all pharmacovigilance activities in compliance with industry regulations.
- Collaborate with clinical research teams, regulatory affairs, and medical affairs to ensure drug safety and compliance.
- Prepare and submit safety reports, including Periodic Safety Update Reports (PSURs) and Risk Management Plans (RMPs).
- Provide training and guidance on pharmacovigilance processes and safety monitoring to internal teams.
Key Skills for this Job Role
Pharmacovigilance
Analytical Thinking
Adverse Event Reporting
ICSR Case Processing
Related Job Vacancies
View All 247 Jobs
Related Job Roles
Clinical Research Associate
Clinical Researcher
Clinical Specialist
Clinical Supervision
Drug Safety Officer
Regulatory Affairs Data Manager (API)
Pharmacovigilance Officer
Cancer Research Assistant
Field Anthropologist
Senior Research Officer
Scientist C (Medical/ Non-Medical)
Scientist-B (Medical/ Non-Medical)
Research Officer
Medical Methodologist
FAQS
How do you define an adverse drug reaction?
An adverse drug reaction is an unwanted or harmful response occurring after the administration of a medication at normal doses. It may range from mild symptoms to serious, life-threatening conditions. Proper identification and reporting are important in pharmacovigilance.
Which information is essential in an Individual Case Safety Report (ICSR)?
An ICSR requires identifiable patient information, reporter details, suspected drug details, and adverse event description. These four minimum criteria are necessary for case validity. Additional clinical information improves assessment quality.
How do you differentiate serious and non-serious adverse events?
Serious adverse events involve outcomes such as death, hospitalization, disability, congenital anomalies, or life-threatening situations. Non-serious events are generally mild and do not cause major medical consequences. Correct classification determines reporting timelines.
How do you assess causality in pharmacovigilance cases?
Causality assessment evaluates the relationship between the suspect drug and adverse event using factors such as timing, dechallenge, rechallenge, and alternative explanations. Standard tools like the WHO-UMC scale may be used. Proper assessment supports accurate safety analysis.
How do you evaluate expectedness in adverse event cases?
Expectedness is determined by comparing reported adverse events with approved product labeling or reference safety information. Events not listed are considered unexpected. This classification affects reporting timelines and regulatory obligations.
Related Job Vacancies
View All 20 Jobs
FAQS
What are the roles and responsibilities of a Pharmacovigilance Executive?
A Pharmacovigilance Executive is responsible for monitoring, documenting, and reporting adverse drug reactions and medication safety information. They process Individual Case Safety Reports (ICSRs), perform MedDRA coding, maintain safety databases, and ensure compliance with global pharmacovigilance regulations. They also assist in literature screening, follow-up activities, signal detection, and preparation of safety documentation.
What qualifications are required to become a Pharmacovigilance Executive?
To become a Pharmacovigilance Executive, candidates generally require a degree in Pharmacy, Life Sciences, Nursing, Medicine, or related healthcare fields. Qualifications such as B.Pharm, M.Pharm, Pharm D, BSc Life Sciences, MSc, BDS, or MBBS are commonly accepted by pharmaceutical companies and CROs.
What skills are required for a Pharmacovigilance Executive?
A Pharmacovigilance Executive must have strong knowledge of adverse event reporting, pharmacovigilance regulations, and medical terminology. Skills in ICSR processing, MedDRA coding, safety database handling, case narrative writing, and data analysis are highly important. They should also possess attention to detail, communication skills, analytical thinking, teamwork ability, and time management skills to meet strict reporting timelines.
What is the average salary of a Pharmacovigilance Executive?
The average salary of a Pharmacovigilance Executive is around ₹3 LPA – ₹8 LPA, which varies depending on qualifications, technical expertise, organization type, and years of experience. Professionals working in multinational pharmaceutical companies and global CROs generally receive better salary packages and career growth opportunities.
What is the career path for Pharmacovigilance professionals?
Pharmacovigilance professionals typically begin as Drug Safety Associates or Pharmacovigilance Executives and gradually progress to Senior Associate, Team Lead, Manager, and Director-level positions. With experience, they may specialize in signal detection, risk management, aggregate reporting, regulatory affairs, or quality assurance. Opportunities are available in pharmaceutical companies, CROs, biotechnology firms, and global drug safety organizations worldwide.
Average Salary among Countries
| Country | Min. Salary Per Year | Max. Salary Per Year |
|---|---|---|
| USA | USD 55000 | USD 95000 |
| United Kingdom | GBP 28000 | GBP 50000 |
| UAE | AED 110000 | AED 240000 |
| Canada | CAD 50000 | CAD 85000 |
| Australia | AUD 60000 | AUD 100000 |
| India | INR 300000 | INR 800000 |
Related Qualifications
Diploma in Medical Writing
MPharm Pharmaceutical Analysis
MPharm Regulatory Affairs
MSc Clinical Research
MS Clinical Research
MWC (Medical Writer Certified)
CMW (Certificate in Medical Writing)
BE Computer Science
Diploma in Clinical Research (DCR)
Certificate in Medical Writing & Regulatory Affairs
Advanced Certificate in Pharmaceutical Regulatory Affairs
Advanced Certificate in Computer-Aided Drug Design (CADD)
PG Diploma in Clinical Research & Data Management
M.Pharm. (Drug Regulatory Affairs)
M.Pharm. (Pharmaceutical Analysis and Quality Assurance)
M.Pharm. (Pharmaceutical Analysis and Quality Control)
MBA Clinical Research
PGDCR (Post Graduate Diploma in Clinical Research)
Post Graduate Diploma in Clinical Research and Pharmacovigilance
Certified Clinical Research Professional (CCRP)
PG Diploma Medical Writing
Advanced PG Diploma Pharmacovigilance
Advanced Diploma in Drug Regulatory Affairs
PG Diploma in Drug Regulatory Affairs
Related Speciality
Medical Writing
Clinical Research
Drug Regulatory Affairs
Pharmaceutical Analysis
Drug Design
Pharmaceutical Research
Pharmaceutical Documentation
Translational Research
Clinical Data Management
Medical Research
3D Printing Drug
Related Course Titles
Bookmark